dominoes fall series fail
Biotech

Krystal discontinues melanoma study after FDA’s Replimune rebuff

The FDA’s rebuff of Replimune’s melanoma candidate has rippled across the industry, prompting Krystal Biotech to shutter a clinical trial.
Gabrielle Masson Aug 21, 2025 10:50am
Investigational Rosnilimab Emerges as a Novel Differentiated Treatment Option for Rheumatoid Arthritis

Investigational Rosnilimab Emerges as a Novel

Aug 18, 2025 8:00am
rainbow kite flying in the sky

Kite sails into in vivo CAR-T space via $350M Interius buyout

Aug 21, 2025 9:59am
accelerated

FDA aims for September approval decision for Stealth's drug

Aug 21, 2025 10:15am
Dark and dramatic sky with sunlight

After 'complete standstill,' biotech market reaches new normal

Aug 20, 2025 11:04am
Apple Watch pulse oximeter

Masimo sues US Customs over Apple Watch pulse ox green light

Aug 21, 2025 11:15am
More News
Fierce Pharma

Sarepta extends $700M debt to 2030 amid Elevidys uncertainty

Aug 21, 2025 10:52am

Dynavax's vaccine holds its own against Shingrix in early test

Aug 21, 2025 8:00am
Fierce Healthcare

After shooting, HHS staff call for RFK to stop sowing mistrust

Aug 20, 2025 1:38pm

IQVIA, Veeva go from adversaries to partners

Aug 20, 2025 1:32pm